Which hedge funds own DRUG? BRIGHT MINDS BIOSCIENCES INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
6 of the hedge funds tracked by WhaleCreep disclosed a position in DRUG (BRIGHT MINDS BIOSCIENCES INC) in their Q2 2026 13F filings, worth $54.7m in total. The largest holder by portfolio weight is RA Capital Management at 0.2% of its book. 3 managers opened a new position this quarter: Point72 Asset Management LP, Citadel Advisors, Tudor Investment. 1 exited: D. E. Shaw & Co.
6tracked managers holding
3opened this quarter
1exited this quarter
Which hedge funds hold DRUG? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| RA Capital Management | Q2 2026 | 0.2% | $18.6m | 265,000 | 0% | held |
| Point72 Asset Management LP | Q2 2026 | 0.0% | $23.0m | 327,416 | – | new |
| Woodline Partners | Q2 2026 | 0.0% | $3.2m | 45,668 | 0% | held |
| Millennium Management | Q2 2026 | 0.0% | $4.7m | 66,740 | 26% | added |
| Citadel Advisors | Q2 2026 | 0.0% | $4.7m | 66,533 | – | new |
| Tudor Investment | Q2 2026 | 0.0% | $582.0k | 8,291 | – | new |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| D. E. Shaw & Co | 0.0% | $1.1m |
How has hedge fund ownership of DRUG changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 6 | $54.7m |
| Q1 2026 | 4 | $27.7m |
| Q3 2025 | 2 | $6.6m |
| Q2 2025 | 1 | $3.5m |
| Q1 2025 | 2 | $12.3m |
| Q4 2024 | 2 | $21.5m |
| Q4 2023 | 1 | $17.0k |
| Q2 2023 | 1 | $6.0k |
| Q1 2023 | 1 | $12.0k |
Counts every tracked manager that disclosed DRUG in that quarter's filing, including managers that have since stopped filing.